Maxis Clinical Sciences is a real-world evidence consultancy serving pharmaceutical, biotech, biopharma and life sciences companies. We help sponsors generate regulatory-grade RWE, build market access strategies, and make smarter commercial decisions using real-world data. We also partner with CROs, site networks, and healthcare organisations looking to strengthen their RWE capabilities. Our expertise spans RWE advisory, HEOR and epidemiology, market access, revenue management, and digital transformation. From evidence generation to payer engagement to pricing strategy—we connect what happens in trials to what happens in the real world. Ready to discuss your next evidence challenge? Let's connect.
| Website | https://www.maxisclinical.com |
| Revenue | $5.6 million |
| Employees | 27 (21 on RocketReach) |
| Founded | 2022 |
| Address | 510 Thornall St Suite 180, Edison, New Jersey 08837, US |
| Industry | Strategic Management Services |
| Keywords | Real World Evidence, Evidence Based Medicine, Clinical Development, Clinical Research, Clinical Trials, Health Outcomes, Healthcare Technology, Clinical Data, Healthcare Data, Data Analytics, Technology Solutions, Patient Data, Medical Data, Healthcare Consulting, Medical Technology, Life Sciences, Healthcare Services, Biotechnology, Medical Devices, Pharmaceutical |
| Competitors | Oracle, Oracle Health Information, ICON plc, IQVIA, Veeva Systems, Parexel, Medidata Solutions, Celerion, Clinical Research Strategies, LLC, Comprehend Systems, acquired by Saama Technologies (2019) +36 more (view full list) |
Looking for a particular Maxis Clinical Sciences employee's phone or email?
The Maxis Clinical Sciences annual revenue was $5.6 million in 2026.
Harry Ghumman is the Chief People Officer of Maxis Clinical Sciences.
21 people are employed at Maxis Clinical Sciences.
Maxis Clinical Sciences is based in Edison, New Jersey.